Drug Index


Mechanism :

Griseofulvin is fungistatic with in vitro activity against various species of Microsporum Epidermophyton, and Trichophyton. It has no effect on bacteria or on other genera of fungi.

Indication :

  • Fungal infections of nails
  • Athlete’s foot

Contraindications :

This drug is contraindicated in patients with porphyria, hepatocellular failure and in individuals with a history of hypersensitivity to griseofulvin. Males should not father children within 6 months of treatment.

Dosing :

<2 years old:
Safety and efficacy not established.
10-20 mg/kg/day orally in two divided doses. Max: 1 gm/day.
5-15 mg/kg/day orally in two divided doses. Max: 750 mg/day.
Give for 4-6 months for onychomycosis, for 4-8 weeks for tinea pedis, for 2-6 weeks for tinea cruris, for 4-6 weeks for tinea capitis, for 2-4 weeks for tinea corporis, and >6 weeks for tinea barbae.

Adverse Effect :

Hypersensitivity reactions (urticaria, skin rashes, epidermal necrolysis and angioneurotic edema), paresthesias of the hands and feet, diarrhea, oral thrush, headache, fatigue, nausea, vomiting, epigastric distress, dizziness insomnia, mental confusion, nephrosis, proteinuria, hepatic toxicity, leukopenia, GI bleeding and menstrual irregularities.

Interaction :

Warfarin-type anticoagulants: Griseofulvin decreases the activity, dose adjustment of the anticoagulant during and after griseofulvin therapy may be required.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function
HDNot dialysed. Dose as in normal renal function
HDF/High fluxNot dialysed. Dose as in normal renal function
CAV/VVHDNot dialysed. Dose as in normal renal function

Hepatic Dose :

Griseofulvin undergoes hepatic metabolism.
Mild to moderate hepatic impairment: No dosage adjustment is required. Regular monitoring of liver function is recommended.
Severe hepatic impairment: Use is contraindicated.
12/24/2023 09:14:25 Griseofulvin
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0